Emblaveo
Submitted by Anonymous (not verified) on 20 March 2025 - 9:30
Emblaveo
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 19 March 2025 - 15:56
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised
PSUSA/00010511/202407
Submitted by Anonymous (not verified) on 19 March 2025 - 15:50
PSUSA/00010511/202407
Human medicines European public assessment report (EPAR): Tenofovir disoproxil Zentiva, tenofovir disoproxil, Date of authorisation: 15/09/2016, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 19 March 2025 - 15:49
Human medicines European public assessment report (EPAR): Tenofovir disoproxil Zentiva, tenofovir disoproxil, Date of authorisation: 15/09/2016, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 19 March 2025 - 15:45
Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation: 21/06/2021, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 19 March 2025 - 15:40
Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation: 21/06/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Re
Submitted by Anonymous (not verified) on 19 March 2025 - 15:34
Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/11/2016, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 19 March 2025 - 15:05
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/11/2016, Revision: 10, Status: Authorised
PSUSA/00002944/202407
Submitted by Anonymous (not verified) on 19 March 2025 - 14:03
PSUSA/00002944/202407
PSUSA/00002087/202407
Submitted by Anonymous (not verified) on 19 March 2025 - 13:50
PSUSA/00002087/202407